Foresite Capital Management III, LLC - VERONA PHARMA PLC ownership

VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 100 filers reported holding VERONA PHARMA PLC in Q3 2023. The put-call ratio across all filers is 3.08 and the average weighting 0.6%.

Quarter-by-quarter ownership
Foresite Capital Management III, LLC ownership history of VERONA PHARMA PLC
ValueSharesWeighting
Q3 2022$11,356,000
+143.9%
1,111,1120.0%29.98%
+77.5%
Q2 2022$4,656,000
-16.0%
1,111,1120.0%16.89%
-0.0%
Q1 2022$5,544,000
-25.8%
1,111,1120.0%16.90%
-10.6%
Q4 2021$7,467,000
+22.6%
1,111,1120.0%18.90%
+123.9%
Q3 2021$6,089,000
-16.2%
1,111,1120.0%8.44%
+9.6%
Q2 2021$7,267,000
-21.8%
1,111,1120.0%7.70%
-5.6%
Q1 2021$9,289,000
+34.0%
1,111,1120.0%8.16%
+58.0%
Q3 2020$6,933,000
+247.7%
1,111,112
+437.6%
5.16%
+688.1%
Q4 2018$1,994,000
-68.2%
206,663
-58.7%
0.66%
-52.6%
Q3 2018$6,266,000
-8.8%
500,883
-0.4%
1.38%
-6.5%
Q2 2018$6,869,000
-39.2%
502,825
-11.1%
1.48%
-40.0%
Q1 2018$11,306,000
+80.2%
565,292
+7.0%
2.46%
+40.0%
Q4 2017$6,273,000
-32.9%
528,422
-13.2%
1.76%
-31.6%
Q3 2017$9,346,000
+30.7%
608,851
-0.8%
2.57%
+10.2%
Q2 2017$7,152,000613,6012.34%
Other shareholders
VERONA PHARMA PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,332,485$34,817,83322.99%
Abingworth LLP 2,457,500$64,214,47520.92%
Fairmount Funds Management LLC 2,875,526$75,137,49411.92%
Octagon Capital Advisors LP 2,468,000$64,488,84010.04%
NEA Management Company, LLC 5,584,753$145,929,5968.20%
Knoll Capital Management, LLC 95,391$2,492,5675.62%
Frazier Life Sciences Management, L.P. 2,815,720$73,574,7644.57%
Resolute Capital Asset Partners LLC 185,992$4,8604.34%
Caligan Partners LP 183,064$4,783,4623.98%
Samsara BioCapital, LLC 695,001$18,160,3763.91%
View complete list of VERONA PHARMA PLC shareholders